BETSY GERACI: Open Payments
NPI 1336574839 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,147 in 45 payments from 12 companies in 2025. Trend: 2023 $814 · 2024 $1,198 · 2025 $1,147
Food & beverage: $1,147
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $388 |
| Novo Nordisk Inc | 3 | $156 |
| ABBVIE INC. | 13 | $140 |
| Alnylam Pharmaceuticals Inc. | 4 | $102 |
| Lilly USA, LLC | 4 | $81 |
| Amgen Inc. | 5 | $78 |
| PFIZER INC. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Exact Sciences Corporation | 2 | $46 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: BREZTRI, Wegovy, GIVLAARI, VRAYLAR, OTEZLA, FARXIGA, ELIQUIS, CAPLYTA.
Industry payments across FL — which companies pay providers there.
